| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Cytomed Therapeutics Limited (GDTC) have been net buyers, picking up 400,000 shares worth roughly $600K on balance. In the past 30 days, 1 insider bought and 0 sold. Purchases have clustered in the most recent filings.
Leading the buying is Choo Chee Kong (Director, 10% Owner), now holding an estimated $945K in GDTC.
GDTC sits in the Biotechnology industry within the Healthcare sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 630.3K | $598.2K | +200.0K |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 20, 2026 | Choo Chee Kong | Director, 10% Owner | Buy | 200,000 | $1.50 | $300,000.00 | +20.8% | - | - | |
| Jul 20, 2026 | Choo Chee Kong | Director, 10% Owner | Buy | 200,000 | $1.50 | $300,000.00 | +20.8% | - | - |